Lorvent TH 8mg/4mg Tablet

Introduction

Lorvent TH is a prescription medication that combines two active ingredients: Lornoxicam and Thiocolchicoside. It is available in tablet form and is used for the treatment of certain painful conditions and inflammation.

Uses

Lorvent TH is primarily prescribed to relieve pain and reduce inflammation associated with conditions such as musculoskeletal disorders, including sprains, strains, and muscle spasms. It may also be used to manage post-operative pain and inflammatory conditions such as arthritis.

Dosage and Administration

The dosage of Lorvent TH may vary depending on the severity of the condition and the individual patient. Follow the instructions provided by your healthcare provider. Generally, the recommended dose is one tablet taken orally, with or without food. It is typically taken once or twice daily, as directed by your doctor. Do not exceed the prescribed dose.

Mechanism of Action

Lornoxicam, one of the active ingredients in Lorvent TH, belongs to a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by inhibiting the production of certain chemicals in the body that cause pain and inflammation. Thiocolchicoside, on the other hand, is a muscle relaxant that acts by reducing muscle spasms and relieving associated pain.

Side Effects

Common side effects include nausea, vomiting, indigestion, dizziness, and headache. These side effects are generally mild and temporary. However, if you experience any severe or persistent side effects, such as difficulty breathing, chest pain, or allergic reactions, seek immediate medical attention.

Drug Interactions

Lorvent TH may interact with certain medications, herbal supplements, or substances. Inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and herbal supplements, to avoid any potential interactions. Some medications that may interact with Lorvent TH include other NSAIDs, anticoagulants, and certain blood pressure medications. Your doctor will be able to provide you with specific guidance regarding potential drug interactions.

Precautions

Before taking Lorvent TH, inform your healthcare provider about any pre-existing medical conditions, allergies, or sensitivities you may have. This medication may not be suitable for individuals with a history of gastrointestinal ulcers, bleeding disorders, kidney or liver problems, or certain heart conditions. Avoid alcohol consumption while taking Lorvent TH, as it may increase the risk of certain side effects. Additionally, this medication should not be used during pregnancy or while breastfeeding without consulting a healthcare professional.

Storage

Patient Tips

• Take Lorvent TH exactly as prescribed by your healthcare provider. Do not exceed the recommended dose or change the dosing schedule without consulting your doctor.
• If you experience any side effects or have concerns while taking this medication, contact your healthcare provider for further guidance.
• Inform your doctor about any other medications or supplements you are taking before starting Lorvent TH to avoid potential drug interactions.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Do not stop taking Lorvent TH abruptly without consulting your doctor, as this may lead to a recurrence of symptoms or other complications.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Lornoxicam (International database) (Drugs.com) [Accessed 28 Jun. 2024] (online) Available at:
• Ahmed MO, Al-Badr AA. Lornoxicam. Profiles Drug Subst Excip Relat Methodol. 2011;36:205-39. doi: 10.1016/B978-0-12-387667-6.00006-3. Epub 2011 Jun 23. [Accessed 6 Jun. 2024] Available at:
• Cangrelor Advanced Patient Information Consumer Information (Micromedex) (Drugs.com) [Accessed 1 Jun. 2024] (online) Available at:
• Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam. Clin Pharmacokinet. 1998 Jun;34(6):421-8. doi: 10.2165/00003088-199834060-00001. [Accessed 20 Jun. 2024] Available at: